These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3320720)

  • 41. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension.
    Moser M; Lunn J; Materson BJ
    Am J Cardiol; 1985 Dec; 56(16):101H-104H. PubMed ID: 4072939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial antihypertensive therapy. Comparison of prazosin and hydrochlorothiazide.
    Alderman MH; Davis TK; Carroll L
    Am J Med; 1986 Feb; 80(2A):120-5. PubMed ID: 3511691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA; Materson BJ; Reda DJ; Williams DW; Hamburger RJ; Cushman WC; Anderson RJ
    JAMA; 1998 Oct; 280(13):1168-72. PubMed ID: 9777817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do diuretics have antihypertensive properties independent of natriuresis?
    Bennett WM; McDonald WJ; Kuehnel E; Hartnett MN; Porter GA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):499-504. PubMed ID: 334435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.
    Kohvakka A; Salo H; Gordin A; Eisalo A
    Acta Med Scand; 1986; 219(4):381-6. PubMed ID: 3521208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of hydrochlorothiazide, diltiazem and enalapril on mononuclear cell sodium and magnesium levels in systemic hypertension.
    Abraham AS; Brooks BA; Grafstein Y; Barchilon E; Nubani N; Eylath U; Shemesh O
    Am J Cardiol; 1991 Nov; 68(13):1357-61. PubMed ID: 1951126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocrine and vascular responses in hypertensive patients to long-term treatment with diltiazem.
    Swartz SL
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):391-5. PubMed ID: 2438500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The determinants of response to diltiazem in hypertension.
    Shepherd AM; LeForce C; Park GD; Hoop RS; Weir S
    Clin Pharmacol Ther; 1991 Sep; 50(3):338-49. PubMed ID: 1914368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension.
    Zemel PC; Zemel MB; Urberg M; Douglas FL; Geiser R; Sowers JR
    Am J Clin Nutr; 1990 Apr; 51(4):665-9. PubMed ID: 2181860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Return of elevated blood pressure after withdrawal of antihypertensive drugs.
    Circulation; 1975 Jun; 51(6):1107-13. PubMed ID: 1093758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic consequences of antihypertensive therapy.
    Flamenbaum W
    Ann Intern Med; 1983 May; 98(5 Pt 2):875-80. PubMed ID: 6847029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diltiazem-associated hyperpigmentation.
    Campbell M; Ahluwalia J; Watson AC
    J Gen Intern Med; 2013 Dec; 28(12):1676. PubMed ID: 23846341
    [No Abstract]   [Full Text] [Related]  

  • 53. [Photodistributed hyperpigmentation with diltiazem].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2002 Nov; 129(11):1332. PubMed ID: 12514530
    [No Abstract]   [Full Text] [Related]  

  • 54. [EFFECT OF HYDROCHLOROTHIAZIDE ON THE URIC ACID LEVEL IN THE BLOOD SERUM].
    SZOSTAK WB; GIZINSKA H
    Pol Tyg Lek; 1964 Dec; 19():1918-9. PubMed ID: 14312853
    [No Abstract]   [Full Text] [Related]  

  • 55. Do beta-blockers and thiazides reduce fracture risk?
    Bhandari M; Devereaux PJ
    CMAJ; 2005 Jan; 172(1):37. PubMed ID: 15632401
    [No Abstract]   [Full Text] [Related]  

  • 56. Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
    Buckley MM; Grant SM; Goa KL; McTavish D; Sorkin EM
    Drugs; 1990 May; 39(5):757-806. PubMed ID: 2191851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal-metabolic consequences of antihypertensive therapy with diltiazem versus hydrochlorothiazide.
    Zawada ET; Williams L; McClung DE; TerWee JA; Horning J; McNulty R; Thomas M; Simmons J
    Miner Electrolyte Metab; 1987; 13(2):72-7. PubMed ID: 3320720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
    Manning G; Joy A; Mathias CJ; McDonald CJ; Millar-Craig MW
    J Hum Hypertens; 1996 Jul; 10(7):443-8. PubMed ID: 8880557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized double-blind clinical trial of xipamid and hydrochlorothiazide in essential hypertension.
    Kumar S; Pandhi P; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):549-51. PubMed ID: 6392119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.